unknown
Stage
1
Investors
About
Biossil is an AI native biopharma company based in Toronto developing personalized drug trials and advancing late-stage programs addressing life-threatening diseases such as Sickle Cell Disease, Glioblastoma, and Alzheimer's Disease.
Explore Biossil's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.